ENTX (Entera Bio) Buyback Yield %: -0.09 (As of Jul. 04, 2026)


ENTX Entera Bio Ltd ENTX
23 GF Score
Price $1.66
! 2 Warning Signs
View Full Analysis

What is Entera Bio Buyback Yield %?

Entera Bio ENTX -2.92% 23 Buyback Yield % is -0.09 as of Jul. 04, 2026. GuruFocus rates ENTX with a GF Score™ of 23/100. The stock has 2 warning signs investors should review. Among 744 Biotechnology companies, Entera Bio ranks better than 82.39% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Entera Bio's current buyback yield was -0.09%.

Entera Bio Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Entera Bio's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entera Bio Buyback Yield % Chart

Entera Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.89 0.00 -31.08 -4.81 -15.01

Entera Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.12 -15.49 -15.33 -15.01 -0.14

ENTX vs HRTX, OKYO, EDSA: Buyback Yield % Comparison

For the Biotechnology subindustry, Entera Bio's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entera Bio Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entera Bio's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Entera Bio's Buyback Yield % falls into.


ENTX
23GF Score
Entera Bio Ltd ENTX
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Entera Bio Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Entera Bio's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 13.444) / 89.58726
=-15.01%

Entera Bio's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.071) / 51.75042
=-0.14%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -0.09 mean?
Entera Bio (ENTX) has a Buyback Yield % of -0.09 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Entera Bio and its competitors. According to the industry distribution chart, Entera Bio ranks #131 out of 744 companies in the Biotechnology industry, placing it in the top 17.6%.
Is Entera Bio's Buyback Yield % too high?
Entera Bio's current Buyback Yield % is -0.09. Based on the distribution chart, Entera Bio ranks #131 out of 744 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Entera Bio has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Entera Bio's Buyback Yield % compare to HRTX and OKYO?
According to the Biotechnology industry distribution chart, Entera Bio ranks #131 out of 744 companies for Buyback Yield %. This places Entera Bio in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Entera Bio and its competitors. Entera Bio's current Buyback Yield % is -0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entera Bio stock overvalued right now?
Entera Bio (ENTX) has a current Buyback Yield % of -0.09. The current Buyback Yield % is -0.09. Entera Bio's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Entera Bio (ENTX), the current Buyback Yield % is -0.09 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entera Bio Business Description

Other Exchanges 5DT:Germany
Address Kiryat Hadassah, Minrav Building - Fifth Floor, Hadassah Bio Park, Jerusalem, ISR, 9112002
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.
23GF Score

Get the complete analysis for ENTX

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.66
Price